Filters
Statements

Statements

BERLIN DECLARATION - Biopharmaceutical Industry Vision for Equitable Access in Pandemics

BERLIN DECLARATION - Biopharmaceutical Industry Vision for Equitable Access in Pandemics

19 July 2022
News Releases

News Releases

Pharma proposes to work with G7 and G20 on a joint solution for better access to vaccines and treatments around the world for future pandemics

Pharma proposes to work with G7 and G20 on a joint solution for better access

19 July 2022
Publications

Publications

10 Leçons Tirées de la Pandémie de la COVID-19 Pour Créer un Monde en Meilleur Santé et Plus Équitable

10 Leçons Tirées de la Pandémie de la COVID-19 Pour Créer un Monde en Meilleur

13 July 2022
Publications

Publications

IFPMA Artificial Intelligence Principles

IFPMA Artificial Intelligence Principles

29 June 2022
Position Papers

Position Papers

Policy brief: Regulatory agilities applied during COVID-19

Policy brief: Regulatory agilities applied during COVID-19

23 June 2022
News Releases

News Releases

Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany and global pandemic response involving the G7

Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany

21 June 2022
News Releases

News Releases

Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the World Trade Organization Ministerial Conference

Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the

17 June 2022
Statements

Statements

IFPMA’s comments on annotated outline of a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response

IFPMA’s comments on annotated outline of a WHO convention, agreement or other international instrument on

15 June 2022
Position Papers

Position Papers

Clinical research in resource-limited settings

Clinical research in resource-limited settings

09 June 2022
Statements

Statements

Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)

Research-based biopharmaceutical industry on the TRIPS waiver discussions at WTO Ministerial Conference (MC12)

09 June 2022